HUTCHMED (China) Ltd. is a holding company, which engages in the research and development, manufacture, and sale of pharmaceuticals and health-oriented consumer products. It operates through the Oncology/Immunology and Other Ventures segments. The Oncology/Immunology segment includes the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The Other Ventures segment involves the other commercial businesses which include the sales, marketing, manufacture, and distribution of prescription drugs and healthcare products. The company was founded on December 18, 2000 and is headquartered in Hong Kong.

KLX Energy Services Holdings, Inc. engages in the provision of completion, intervention and production services and products to onshore oil and gas producing regions. It operates through the following geographical segments: Southwest, Rocky Mountains and Northeast. The company was founded in 2018 and is headquartered in Houston, TX.

Bowen Acquisition Corp. is a blank check company that was formed for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on February 17, 2023 and is headquartered in New York, NY.

Drilling Tools International Corp. engages in the provision of rentals of directional drilling tools, wellbore optimization tools and other drilling products. The company was founded in 1984 and is headquartered in Houston, TX.

Mereo BioPharma Group Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that aim to improve outcomes for oncology and rare diseases. Its portfolio include Etigilimab (MPH-313), Alvelestat (MPH-966), Setrusumab (BPS-804), Navicixizumab (OMP-305B83), Acumapimod (BCT-197), and Leflutrozole (BGS-649). The company was founded by Denise Vera Scots-Knight, Charles Edward Sermon, Alastair Graham MacKinnon, and John P. Richard in March 10, 2015 and is headquartered in London, the United Kingdom.

Nature Wood Group Ltd. is a holding company, which engages in forest management, harvesting and down-stream wood processing and distribution of logs, decking, flooring, and sawn timber products. It operates through the Direct Purchase and ODM, and Manufacturing Segments. The Direct Purchase and ODM segment represent sourcing of live wood and owning designed design on wood products for sales to end customers. The Manufacturing segment is involved in manufacturing decking, flooring, or sawn timbers. The company was founded on September 22, 2011 and is headquartered in Macau, China.

Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes Compass platform, which allows to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization. The company was founded by Mark Daly, Aaron D. Gitler, Stephen Elledge, Sekar Kathiresan, and Jonathan S. Weissman on August 28, 2019 and is headquartered in San Francisco, CA.

Metallus, Inc. engages in the manufacture of alloy, carbon and micro-alloy steel products. The firm's products include special bar quality steel, seamless mechanical tubing, gears, grades of steel, jumbo bloom vertical caster, TimkenSteel ultrapremium technology, and TimkenSteel endurance steels. Its services include thermal treatment, value added components, technical support and testing, supply chain, and TimkenSteel portal. The company was founded on October 24, 2013 and is headquartered in Canton, OH.

Inspire Veterinary Partners, Inc. engages in the business of operating small animal general practice hospitals which serve all manner of companion pets, emphasizing canine, and feline breeds and including equine care. The firm is also involved in acquiring additional veterinary hospitals including general practice, mixed animal facilities, and critical and emergency care. The company was founded on December 2, 2020 and is headquartered in Virginia Beach, VA.

Avalo Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the treatment of immune dysregulation by developing therapies that target the LIGHT-signaling network. It also focuses on reducing LIGHT levels which can moderate immune dysregulation in many acute and chronic inflammatory disorders. The company was founded by Blake M. Paterson, Isaac Blech, Barbara S. Slusher, and Solomon H. Snyder on January 31, 2011 and is headquartered in Rockville, MD.